Pentamidine for Prophylaxis against Pneumocystis jiroveciiPneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy

Autor: Quinn, Melissa, Fannin, J. T., Sciasci, Joseph, Bragg, Allison, Campbell, Patrick K., Carias, Delia, Crews, Kristine R., Gregornik, David, Jeha, Sima, Maron, Gabriela, Pauley, Jennifer L., Swanson, Hope D., Wolf, Joshua, Greene, William
Zdroj: Antimicrobial Agents and Chemotherapy; May 2018, Vol. 62 Issue: 8
Abstrakt: Pneumocystis jiroveciipneumonia is a life-threatening opportunistic infection in children receiving immunosuppressive chemotherapy. Without prophylaxis, up to 25% of pediatric oncology patients receiving chemotherapy will develop Pneumocystis jiroveciipneumonia.
Databáze: Supplemental Index